BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30558250)

  • 21. Phosphorylation of cyclophilin D at serine 191 regulates mitochondrial permeability transition pore opening and cell death after ischemia-reperfusion.
    Hurst S; Gonnot F; Dia M; Crola Da Silva C; Gomez L; Sheu SS
    Cell Death Dis; 2020 Aug; 11(8):661. PubMed ID: 32814770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.
    Lim SY; Hausenloy DJ; Arjun S; Price AN; Davidson SM; Lythgoe MF; Yellon DM
    J Cell Mol Med; 2011 Nov; 15(11):2443-51. PubMed ID: 21143389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the mitochondrial permeability transition pore modulates Ca2+ responses to physiological stimuli in adult neurons.
    Barsukova A; Komarov A; Hajnóczky G; Bernardi P; Bourdette D; Forte M
    Eur J Neurosci; 2011 Mar; 33(5):831-42. PubMed ID: 21255127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.
    Cannino G; Urbani A; Gaspari M; Varano M; Negro A; Filippi A; Ciscato F; Masgras I; Gerle C; Tibaldi E; Brunati AM; Colombo G; Lippe G; Bernardi P; Rasola A
    Cell Death Differ; 2022 Dec; 29(12):2335-2346. PubMed ID: 35614131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of mitochondrial permeability transition pore (mPTP) in cardiac arrhythmias: Evidence from cyclophilin D knockout mice.
    Gordan R; Fefelova N; Gwathmey JK; Xie LH
    Cell Calcium; 2016 Dec; 60(6):363-372. PubMed ID: 27616659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophilin D regulates the dynamic assembly of mitochondrial ATP synthase into synthasomes.
    Beutner G; Alanzalon RE; Porter GA
    Sci Rep; 2017 Nov; 7(1):14488. PubMed ID: 29101324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.
    Samanta S; Akhter F; Roy A; Chen D; Turner B; Wang Y; Clemente N; Wang C; Swerdlow RH; Battaile KP; Lovell S; Yan SF; Yan SS
    Brain; 2024 May; 147(5):1710-1725. PubMed ID: 38146639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast therapeutic hypothermia prevents post-cardiac arrest syndrome through cyclophilin D-mediated mitochondrial permeability transition inhibition.
    Jahandiez V; Cour M; Bochaton T; Abrial M; Loufouat J; Gharib A; Varennes A; Ovize M; Argaud L
    Basic Res Cardiol; 2017 Jul; 112(4):35. PubMed ID: 28492973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of cyclophilin D prolyl isomerase activity desensitizes mitochondrial permeability transition pore opening in isolated cardiac mitochondria, but does not protect in myocardial ischemia-reperfusion injury.
    Casin KM; Bustamante M; Amanakis G; Sun J; Liu C; Kitsis RN; Murphy E
    J Mol Cell Cardiol; 2023 Oct; 183():67-69. PubMed ID: 37696137
    [No Abstract]   [Full Text] [Related]  

  • 30. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore.
    Pekson R; Liang FG; Axelrod JL; Lee J; Qin D; Wittig AJH; Paulino VM; Zheng M; Peixoto PM; Kitsis RN
    Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2303713120. PubMed ID: 38091291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury.
    Kim SY; Shim MS; Kim KY; Weinreb RN; Wheeler LA; Ju WK
    Cell Death Dis; 2014 Mar; 5(3):e1105. PubMed ID: 24603333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
    Hausenloy DJ; Lim SY; Ong SG; Davidson SM; Yellon DM
    Cardiovasc Res; 2010 Oct; 88(1):67-74. PubMed ID: 20400621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle denervation promotes opening of the permeability transition pore and increases the expression of cyclophilin D.
    Csukly K; Ascah A; Matas J; Gardiner PF; Fontaine E; Burelle Y
    J Physiol; 2006 Jul; 574(Pt 1):319-27. PubMed ID: 16675492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophilin 40 alters UVA-induced apoptosis and mitochondrial ROS generation in keratinocytes.
    Jandova J; Janda J; Sligh JE
    Exp Cell Res; 2013 Mar; 319(5):750-60. PubMed ID: 23220213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition.
    Gutiérrez-Aguilar M; Douglas DL; Gibson AK; Domeier TL; Molkentin JD; Baines CP
    J Mol Cell Cardiol; 2014 Jul; 72():316-25. PubMed ID: 24768964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Cyclophilin D and Calcium in Isoflurane-induced Preconditioning.
    Teixeira G; Chiari P; Fauconnier J; Abrial M; Couture-Lepetit E; Harisseh R; Pillot B; Lacampagne A; Tourneur Y; Gharib A; Ovize M
    Anesthesiology; 2015 Dec; 123(6):1374-84. PubMed ID: 26460965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.
    Amanakis G; Sun J; Fergusson MM; McGinty S; Liu C; Molkentin JD; Murphy E
    Cardiovasc Res; 2021 Jan; 117(1):212-223. PubMed ID: 32129829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclophilin D in mitochondrial pathophysiology.
    Giorgio V; Soriano ME; Basso E; Bisetto E; Lippe G; Forte MA; Bernardi P
    Biochim Biophys Acta; 2010; 1797(6-7):1113-8. PubMed ID: 20026006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CypD(-/-) hearts have altered levels of proteins involved in Krebs cycle, branch chain amino acid degradation and pyruvate metabolism.
    Menazza S; Wong R; Nguyen T; Wang G; Gucek M; Murphy E
    J Mol Cell Cardiol; 2013 Mar; 56():81-90. PubMed ID: 23262437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
    Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
    J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.